Dietary supplements and cancer prevention: Balancing potential benefits against proven harms

Journal of the National Cancer Institute

Volumn 104, Issue 10, 2012, Pages 732-739

  Martínez, María Elena ^a   Jacobs, Elizabeth T ^b   Baron, John A ^c   Marshall, James R ^d   Byers, Tim ^e,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f Global Health and Health Disparities   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CALCIUM; FOLIC ACID; VITAMIN D;

ANTINEOPLASTIC ACTIVITY; CANCER PREVENTION; CANCER RISK; DIET SUPPLEMENTATION; DRUG MARKETING; GOVERNMENT REGULATION; HUMAN; NONHUMAN; OFF LABEL DRUG USE; PRIORITY JOURNAL; REVIEW;

ANTIOXIDANTS; CALCIUM COMPOUNDS; CHRONIC DISEASE; DIETARY SUPPLEMENTS; FOLIC ACID; HUMANS; NEOPLASMS; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SAFETY; SOCIAL MARKETING; TRACE ELEMENTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VITAMIN B COMPLEX; VITAMIN D; VITAMINS;

EID: 84861312865     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs195     Document Type: Review

References (93)

1. Dietary Supplement Health and Education Act of 1994. Pub. L. No. 103-417. 103rd Congress. Oct. 25, 1994.
2. Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids: Food and Nutrition Board. Washington, DC: Institute of Medicine; 2000.
3. Chernoff R. Micronutrient requirements in older women. Am J Clin Nutr. 2005;81(5):1240S-1245S.
4. Gahche J, Bailey R, Burt V, et al. Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994). NCHS Data Brief. 2011;(61):1-8.
5. Chan AL, Leung HW, Wang SF. Multivitamin supplement use and risk of breast cancer: a meta-analysis. Ann Pharmacother. 2011;45(4):476-484.
6. Cho E, Hunter DJ, Spiegelman D, et al. Intakes of vitamins A, C and E and folate and multivitamins and lung cancer: a pooled analysis of 8 prospective studies. Int J Cancer. 2006;118(4):970-978.
7. Park Y, Spiegelman D, Hunter DJ, et al. Intakes of vitamins A, C, and E and use of multiple vitamin supplements and risk of colon cancer: a pooled analysis of prospective cohort studies. Cancer Causes Control. 2010;21(11):1745-1757.
8. Stratton J, Godwin M. The effect of supplemental vitamins and minerals on the development of prostate cancer: a systematic review and meta-analysis. Fam Pract. 2011;28(3):243-252.
9. Cohen PA. Assessing supplement safety-the FDA's controversial proposal. N Engl J Med. 2012;366(5):389-391.
10. Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates? Nature. 1981;290(5803):201-208.
11. Graham S. Diet and cancer. Am J Epidemiol. 1980;112(2):247-252.
12. Graham S. Results of case-control studies of diet and cancer in Buffalo, New York. Cancer Res. 1983;43(5 suppl):2409s-2413s.
13. Lippman SM, Benner SE, Hong WK. Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis. Cancer Res. 1994;54(7 suppl):2025s-2028s.
14. Ziegler RG. A review of epidemiologic evidence that carotenoids reduce the risk of cancer. J Nutr. 1989;119(1):116-122.
15. Greenberg ER, Baron JA, Stukel TA, et al. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N Engl J Med. 1990;323(12):789-795.
16. Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med. 1994;331(3):141-147.
17. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334(18):1150-1155.
18. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330(15):1029-1035.
19. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334(18):1145-1149.
20. Gaziano JM, Glynn RJ, Christen WG, et al. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2009;301(1):52-62.
21. Lin J, Cook NR, Albert C, et al. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst. 2009;101(1):14-23.
22. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev. 2008;(3):CD004183.
23. Clark L, Combs G, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. JAMA. 1996;276(24):1957-1963.
24. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301(1):39-51.
25. Marshall JR, Tangen CM, Sakr WA, et al. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila). 2011;4(11):1761-1769.
26. Karp DD, Lee SJ, Shaw-Wright GL, et al. A phase III, intergroup, double-blind, chemoprevention trial of selenium supplementation in resected stage I non-small cell lung cancer (NSCLC). J Clin Oncol. 2010;28(suppl):8s. Abstract CRA7004.
27. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993;85(18):1483-1492.
28. Li JY, Taylor PR, Li B, et al. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst. 1993;85(18):1492-1498.
29. Hercberg S, Galan P, Preziosi P, et al. The SU.VI.MAX study-a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004;164(21):2335-2342.
30. Duffield-Lillico AJ, Reid ME, Turnbull BW, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev. 2002;11(7):630-639.
31. Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549-1556.
32. Bailey LB. Dietary reference intakes for folate: the debut of dietary folate equivalents. Nutr Rev. 1998;56(10):294-299.
33. Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer. 2005;113(5):825-828.
34. Kennedy DA, Stern SJ, Moretti M, et al. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol. 2011;35(1):2-10.
35. Figueiredo JC, Mott LA, Giovannucci E, et al. Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials. Int J Cancer. 2011;129(1):192-203.
36. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007;297(21):2351-2359.
37. Figueiredo JC, Grau MV, Haile RW, et al. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst. 2009;101(6):432-435.
38. Kim YI. Role of folate in colon cancer development and progression. J Nutr. 2003;133(11)(suppl 1):3731S-3739S.
39. Mason JB. Folate, cancer risk, and the Greek god, Proteus: a tale of two chameleons. Nutr Rev. 2009;67(4):206-212.
40. Collin SM, Metcalfe C, Refsum H, et al. Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19(6):1632-1642.
41. Lawson KA, Wright ME, Subar A, et al. Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst. 2007;99(10):754-764.
42. Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr. 2006;83(4):895-904.
43. Foulke J. Folic Acid to Fortify US Food Products to Prevent Birth Defects [press release]. Washington, DC: US Food and Drug Administration; 1996.
44. Ross AC, Taylor CL, Yaktine KL, Del Valle HB. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: Institute of Medicine; 2011.
45. Gandini S, Boniol M, Haukka J, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer. 2011;128(6):1414-1424.
46. Wei MY, Garland CF, Gorham ED, Mohr SB, Giovannucci E. Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17(11):2958-2969.
47. Yin L, Grandi N, Raum E, et al. Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer. 2010;46(12):2196-2205.
48. Yin L, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis of longitudinal studies: serum vitamin D and prostate cancer risk. Cancer Epidemiol. 2009;33(6):435-445.
49. Yin L, Grandi N, Raum E, et al. Meta-analysis: serum vitamin D and colorectal adenoma risk. Prev Med. 2011;53(1-2):10-16.
50. Jacobs ET, Thomson CA, Flatt SW, et al. Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study. Am J Clin Nutr. 2011;93(1):108-117.
51. Jacobs ET, Martinez ME, Jurutka PW. Vitamin D: marker or mechanism of action? Cancer Epidemiol Biomarkers Prev. 2011;20(4):585-590.
52. Manson JE, Mayne ST, Clinton SK. Vitamin D and prevention of cancer-ready for prime time? N Engl J Med. 2011;364(15):1385-1387.
53. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003;326(7387):469.
54. Chlebowski RT, Johnson KC, Kooperberg C, et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008;100(22):1581-1591.
55. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354(7):684-696.
56. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85(6):1586-1591.
57. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Int Med. 2011;155(12):827-838.
58. Chen P, Hu P, Xie D, et al. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat. 2010;121(2):469-477.
59. Van Poppel H, Tombal B. Chemoprevention of prostate cancer with nutrients and supplements. Cancer Manag Res. 2011;3:91-100.
60. Bergsma-Kadijk JA, van 't Veer P, Kampman E, Burema J. Calcium does not protect against colorectal neoplasia. Epidemiology. 1996;7(6):590-597.
61. Martinez ME, Willett WC. Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev. 1998;7(2):163-168.
62. Huncharek M, Muscat J, Kupelnick B. Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutr Cancer. 2009;61(1):47-69.
63. Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med. 1999;340(2):101-107.
64. Bonithon-Kopp C, Kronborg O, Giacosa A, Rath U, Faivre J. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet. 2000;356(9238):1300-1306.
65. Baron JA, Beach M, Wallace K, et al. Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev. 2005;14(3):586-589.
66. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, et al. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010;172(1):81-93.
67. Wolpin BM, Ng K, Bao Y, et al. Plasma 25-hydroxyvitamin d and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2012;21(1):82-91.
68. Albanes D, Mondul AM, Yu K, et al. Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study. Cancer Epidemiol Biomarkers Prev. 2011;20(9):1850-1860.
69. Yetley EA. Multivitamin and multimineral dietary supplements: definitions, characterization, bioavailability, and drug interactions. Am J Clin Nutr. 2007;85(1):269S-276S.
70. Martinez ME, Jacobs ET. Calcium supplementation and prevention of colorectal neoplasia: lessons from clinical trials. J Natl Cancer Inst. 2007;99(2):99-100.
71. Martinez ME, Marshall JR, Giovannucci E. Diet and cancer prevention: the roles of observation and experimentation. Nat Rev Cancer. 2008;8(9):694-703.
72. Yeang CH, McCormick F, Levine A. Combinatorial patterns of somatic gene mutations in cancer. FASEB J. 2008;22(8):2605-2622.
73. Toner CD, Davis CD, Milner JA. The vitamin D and cancer conundrum: aiming at a moving target. J Am Diet Assoc. 2010;110(10):1492-1500.
74. Klein EA. What is the best way to treat high-risk prostate cancer? Cancer. 2011;118(1):12-14.
75. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst. 1996;88(21):1550-1559.
76. Stranges S, Marshall JR, Natarajan R, et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 2007;147(4):217-223.
77. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691.
78. United States Government Accountability Office. Herbal Dietary Supplements. Examples of Deceptive or Questionable Marketing Practices and Potentially Dangerous Advice. 2010; http://www.gao.gov/new.items/d10662t.pdf. Accessed September 10, 2011.
79. US Food and Drug Administration. FDA History. http//www.fda.gov/AboutFDA/ WhatWeDo/History/default.htm. Accessed September 12, 2011.
80. US Food and Drug Administration. Nutritional Labeling and Education Act (NLEA) Requirements. http://www.fda.gov/ICECI/Inspections/InspectionGuides/ ucm074948.htm. Accessed September 12, 2011.
81. Abbott RD, Yin Y, Reed BM, Ygno K. Risk of stroke in male cigarette smokers. N Engl J Med. 1986;315(12):717-720.
82. Denham BE. Dietary supplements-regulatory issues and implications for public health. JAMA. 2011;306(4):428-429.
83. US Food and Drug Administration. Dietary Supplement and Nonprescription Drug Consumer Protection Act. http://www.fda.gov/RegulatoryInformation/ Legislation/FederalFoodDrugandCosmeticActFDCAct/ignificantAmendmentstotheFDCAct/ ucm148035.htm. Accessed September 12, 2011.
84. Senator John McCain introduces the Dietary Supplement Safety Act of 2010 [press release]. February 3. http://mccain.senate.gov/public/index.cfm? FuseAction=PressOffice.Speeches&-ContentRecord-id=952dda07-b71c-4034-4f34- c38974978f7d. Accessed July 15, 2011.
85. Lipton E. Support is mutual for senator and Utah industry. New York Times: NY Times. 2011.
86. Center for Science in the Public Interest. Bayer Sued Over Unsupported Prostate Cancer Claims on One A Day 2009. http://www.cspinet.org/new/200910011- print.html. Accessed January 23, 2012.
87. Kushi LH, Doyle C, McCullough M, et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012;62(1):30-67.
88. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR; 2007.
89. NIH State-of-the-Science Conference Statement on Multivitamin/Mineral Supplements and Chronic Disease Prevention. Ann Intern Med. 2006;145:364-371.
90. Huang HY, Caballero B, Chang S, Multivitamin/Mineral Supplements and Prevention of Chronic Disease. Evidence Report Technology Assessment No. 139. (Prepared by the Johns Hopkins University Evidence-based Practice Center under contract No. 290-02-0018). AHRQ Publication No. 06-E012. Rockville, MD: Agency for Healthcare Research and Quality; 2006.
91. Coutler I, Hardy M, Shekelle PG, Effect of the Supplemental Use of Antioxidants Vitamin C, Vitamin E, and Coenzyme Q10 for the Prevention and Treatment of Cancer. Evidence Reports/Technology Assessments, No. 75. ISBN-10: 1-58763-091-5. Report No.: 03-E047. Rockville, MD.
92. U.S. Preventive Services Task Force. Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale. Ann Int Med. 2003;139(1):51-55.
93. Blendon RJ, DesRoches CM, Benson JM, Brodie M, Altman DE. Americans' views on the use and regulation of dietary supplements. Arch Intern Med. 2001;161(6):805-810.